The fair value of the Company’s derivative contracts, recorded on the Condensed Consolidated Balance Sheets, was as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | Liabilities | | | Balance Sheet Location | | October 31, 2022 | | July 31, 2022 | | October 31, 2022 | | July 31, 2022 | Designated as hedging instruments | | | | | | | | | | | Foreign currency forward contracts | | Other current assets, other long-term assets | | $ | 4.1 | | | $ | 0.3 | | | $ | 2.3 | | | $ | 2.7 | | Net investment hedges | | Other current assets, other long-term assets and other long-term liabilities | | 10.3 | | | 8.2 | | | — | | | — | | | | | | | | | | | | | Total designated | | | | 14.4 | | | 8.5 | | | 2.3 | | | 2.7 | | | | | | | | | | | | | Not designated as hedging instruments | | | | | | | | | Foreign currency forward contracts | | Other current liabilities | | 1.6 | | | 1.7 | | | 2.0 | | | 2.5 | | Total not designated | | | | 1.6 | | | 1.7 | | | 2.0 | | | 2.5 | | Total | | | | $ | 16.0 | | | $ | 10.2 | | | $ | 4.3 | | | $ | 5.2 | | | | | | | | | | | | |
|